2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Cynthia L. Sears, MD, professor of Medicine, at John Hopkins University School of Medicine, member of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, discusses microbiota in patients with colon cancer.
Cynthia L. Sears, MD, professor of Medicine, at Johns Hopkins University School of Medicine, member of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, discusses microbiota in patients with colon cancer.
When single organisms, particularly bacteria such as e-coli or enterotoxigenic bacteroides fragilis, are added to a complex microbiota in a mouse, you increase the numbers of tumors in the colon compared with the background mouse, says Sears.
At a minimum, studying those models helps experts in the field to better understand the mechanisms by which bacteria may be procarcinogenic and allows for the ability to look at humans who have those organisms and see if any of those mechanisms transfer there, explains Sears.
Related Content: